dentalcorp (DNTL) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
21 Nov, 2025Executive summary
Operates the largest national network of dental practices in Canada, with 571 practices as of Q1 2025, serving over 2.3 million active patients and generating $1.6 billion in LTM revenue.
Achieved Q1 2025 revenue of $409.4M, up 9.9% year-over-year, with 4.6% same practice revenue growth and double-digit growth across all key financial metrics since IPO.
Adjusted EBITDA rose 11.5% to $75.9M, with margin expanding 20 bps to 18.5%, and adjusted free cash flow reached $44.3M, up 25.9% year-over-year.
Recurring patient visit rate reached 91.5%, with 92% of patients recurring and active patients up 9.5% year-over-year.
Focuses on organic growth, operational productivity, and acquisitive growth, supported by a scalable technology platform and highly variable cost structure.
Financial highlights
Q1 2025 revenue was $409.4M, up 9.9% year-over-year, with 4.6% same practice revenue growth and adjusted EBITDA of $75.9M, up 11.5% year-over-year.
Adjusted free cash flow was $44.3M, up 25.9% year-over-year, with per-share growth of 15.8% to $0.22.
Gross profit for Q1 2025 was $205.0M, up from $186.4M in Q1 2024.
Net loss and comprehensive loss was $(10.2)M, a slight improvement from $(11.7)M in Q1 2024.
Liquidity at quarter-end was $408M, including $58M in cash and $350M in undrawn debt capacity.
Outlook and guidance
Reaffirmed full-year 2025 guidance: 10-11% revenue growth, 3-5% same practice revenue growth, 20 bps adjusted EBITDA margin improvement, and over $25M in pro forma adjusted EBITDA from acquisitions.
Q2 2025 revenue expected to grow 9-10% year-over-year, with 3-5% same practice revenue growth and 20 bps margin expansion.
Free cash flow expected to continue growing at 15%+ year-over-year.
Latest events from dentalcorp
- Arrangement to acquire all shares for CAD 11 each approved, pending court and closing conditions.DNTL
AGM 20253 Feb 2026 - Q2 revenue and EBITDA grew double digits, with CDCP boosting patient volumes and outlook strong.DNTL
Q2 20242 Feb 2026 - Strong M&A-driven growth, high recurring revenue, and positive outlook define the Canadian dental sector.DNTL
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Double-digit growth, margin expansion, and strong cash flow conversion in Q3 2024.DNTL
Q3 202415 Jan 2026 - 2024 revenue up 8.4% to $1.55B, margin at 18.5%, and 2025 outlook strong.DNTL
Q4 202425 Dec 2025 - Q2 revenue rose 8.9% with 9.9% EBITDA growth, margin expansion, and guidance reaffirmed.DNTL
Q2 202523 Nov 2025 - Double-digit growth, margin expansion, and AI innovation drive leadership in Canadian dentistry.DNTL
Stifel Jaws & Paws Conference 202521 Nov 2025 - Revenue and EBITDA rose double digits; company to be acquired by GTCR at a 33% premium.DNTL
Q3 20256 Nov 2025